Trillium Therapeutics Current Ratio 2013-2020 | TRIL

Trillium Therapeutics current ratio from 2013 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Trillium Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-09-30 $0.30B $0.01B 22.44
2020-06-30 $0.13B $0.01B 12.44
2020-03-31 $0.14B $0.02B 6.06
2019-12-31 $0.02B $0.01B 1.72
2019-09-30 $0.03B $0.01B 2.66
2019-06-30 $0.03B $0.01B 3.43
2019-03-31 $0.04B $0.01B 4.59
2018-12-31 $0.04B $0.01B 3.56
2018-09-30 $0.04B $0.01B 4.33
2018-06-30 $0.05B $0.01B 4.79
2018-03-31 $0.06B $0.01B 5.38
2017-12-31 $0.06B $0.01B 5.75
2017-09-30 $0.05B $0.01B 6.33
2017-06-30 $0.06B $0.01B 7.91
2017-03-31 $0.03B $0.01B 6.07
2016-12-31 $0.04B $0.00B 8.69
2016-09-30 $0.04B $0.00B 11.69
2016-06-30 $0.05B $0.00B 14.15
2016-03-31 $0.05B $0.00B 16.87
2015-12-31 $0.07B $0.00B 25.00
2015-09-30 $0.07B $0.00B 26.97
2015-06-30 $0.07B $0.00B 32.12
2015-03-31 $0.02B $0.00B 7.77
2014-12-31 $0.03B $0.00B 7.80
2014-09-30 $0.03B $0.00B 18.15
2014-06-30 $0.03B $0.00B 27.50
2014-03-31 $0.03B $0.00B 33.16
2013-12-31 $0.03B $0.00B 45.73
2013-09-30 $0.00B $0.00B 5.31
2013-06-30 $0.00B $0.00B 8.72
2013-03-31 $0.00B $0.00B 8.51
2012-12-31 $0.00B $0.00B 8.67
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.168B $0.000B
Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. The company's lead program, SIRPaFc (TTI-621), is a fusion protein that consists of the CD47-binding domain of human SIRPa linked to the Fc region of a human immunoglobulin (IgG1). It is designed to act as a soluble decoy receptor, preventing CD47 from delivering its inhibitory (`do not eat`) signal. Neutralization of the inhibitory CD47 signal enables the activation of macrophage anti-tumor effects by pro-phagocytic (`eat`) signals. A Phase 1 clinical trial (NCT02663518) evaluating SIRPaFc is ongoing. Trillium also has a proprietary medicinal chemistry platform, using unique fluorine chemistry, which permits the creation of new chemical entities from validated drugs and drug candidates with improved pharmacological properties.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.765B 40.32
Takeda Pharmaceutical (TAK) Japan $52.682B 9.66
Astellas Pharma (ALPMY) Japan $29.537B 18.24
Eisai (ESALY) Japan $20.586B 22.83
Catalent (CTLT) United States $19.356B 51.22
Grifols, S.A (GRFS) Spain $11.180B 12.80
Neurocrine Biosciences (NBIX) United States $10.288B 23.86
Jazz Pharmaceuticals (JAZZ) Ireland $9.465B 15.81
Arrowhead Pharmaceuticals (ARWR) United States $8.268B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.603B 0.00
United Therapeutics (UTHR) United States $7.447B 14.46
Ionis Pharmaceuticals (IONS) United States $7.381B 0.00
IPSEN SA ADR (IPSEY) France $7.175B 0.00
Evotec AG (EVTCY) Germany $6.372B 430.30
Orion OYJ (ORINY) Finland $5.794B 0.00
Sage Therapeutics (SAGE) United States $4.962B 0.00
ChemoCentryx (CCXI) United States $4.695B 0.00
FibroGen (FGEN) United States $4.553B 0.00
Tilray (TLRY) Canada $4.184B 0.00
Nektar Therapeutics (NKTR) United States $4.071B 0.00
PTC Therapeutics (PTCT) United States $3.896B 0.00
Cronos Group (CRON) Canada $3.765B 0.00
Hypermarcas (HYPMY) Brazil $3.659B 14.44
Pacira BioSciences (PCRX) United States $3.193B 54.44
Revolution Medicines (RVMD) United States $3.032B 0.00
Corcept Therapeutics (CORT) United States $2.950B 29.59
Xencor (XNCR) United States $2.855B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.735B 16.94
AlloVir (ALVR) United States $2.380B 0.00
Sundial Growers (SNDL) Canada $2.077B 0.00
USANA Health Sciences (USNA) United States $2.042B 16.56
BioCryst Pharmaceuticals (BCRX) United States $1.903B 0.00
Endo (ENDP) Ireland $1.826B 2.76
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.783B 0.00
Translate Bio (TBIO) United States $1.735B 0.00
ImmunoGen (IMGN) United States $1.704B 0.00
Heron Therapeutics (HRTX) United States $1.652B 0.00
Organogenesis Holdings (ORGO) United States $1.639B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.616B 10.36
Ironwood Pharmaceuticals (IRWD) United States $1.486B 11.68
Ocular Therapeutix (OCUL) United States $1.391B 0.00
Indivior (INVVY) United States $1.316B 0.00
Zogenix (ZGNX) United States $1.181B 0.00
Aclaris Therapeutics (ACRS) United States $1.154B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.060B 0.00
Karyopharm Therapeutics (KPTI) United States $1.031B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.995B 0.00
Vectura Group (VEGPF) United Kingdom $0.952B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Radius Health (RDUS) United States $0.873B 0.00
Aerie Pharmaceuticals (AERI) United States $0.861B 0.00
Collegium Pharmaceutical (COLL) United States $0.820B 31.04
VAXART, INC (VXRT) United States $0.783B 0.00
Esperion Therapeutics (ESPR) United States $0.765B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.701B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.701B 0.00
Chinook Therapeutics (KDNY) United States $0.697B 0.00
Altimmune (ALT) United States $0.592B 0.00
KalVista Pharmaceuticals (KALV) United States $0.590B 0.00
Rafael Holdings (RFL) United States $0.588B 0.00
Ardelyx (ARDX) United States $0.582B 0.00
Acutus Medical (AFIB) United States $0.578B 0.00
Summit Therapeutics (SMMT) United States $0.559B 0.00
Molecular Templates (MTEM) United States $0.545B 0.00
Flexion Therapeutics (FLXN) United States $0.543B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.503B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.501B 0.00
Akebia Therapeutics (AKBA) United States $0.500B 0.00
Harpoon Therapeutics (HARP) United States $0.490B 0.00
Siga Technologies (SIGA) United States $0.489B 13.74
AVITA Medical (RCEL) United States $0.470B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.469B 0.00
TherapeuticsMD (TXMD) United States $0.456B 0.00
DURECT (DRRX) United States $0.451B 0.00
PROFOUND MEDICL (PROF) Canada $0.445B 0.00
Jounce Therapeutics (JNCE) United States $0.438B 0.00
MEI Pharma (MEIP) United States $0.422B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.403B 10.51
Redhill Biopharma (RDHL) Israel $0.395B 0.00
VYNE Therapeutics (VYNE) United States $0.383B 0.00
Innate Pharma SA (IPHYF) France $0.356B 0.00
Nature's Sunshine Products (NATR) United States $0.324B 20.86
CASI Pharmaceuticals (CASI) United States $0.305B 0.00
Alpine Immune Sciences (ALPN) United States $0.279B 0.00
Xeris Pharmaceuticals (XERS) United States $0.267B 0.00
Onconova Therapeutics (ONTX) United States $0.258B 0.00
Oncternal Therapeutics (ONCT) United States $0.255B 0.00
Lannett Co Inc (LCI) United States $0.251B 8.42
Jaguar Animal Health (JAGX) United States $0.247B 0.00
CTI BioPharma (CTIC) United States $0.245B 0.00
IMV INC (IMV) Canada $0.223B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.219B 0.00
Concert Pharmaceuticals (CNCE) United States $0.215B 0.00
Novan (NOVN) United States $0.214B 0.00
Calithera Biosciences (CALA) United States $0.206B 0.00
OptiNose (OPTN) United States $0.202B 0.00
Iterum Therapeutics (ITRM) Ireland $0.199B 0.00
Taiwan Liposome (TLC) Taiwan $0.198B 0.00
Qilian Holding Group (QLI) China $0.197B 0.00
Infinity Pharmaceuticals (INFI) United States $0.195B 0.00
Nutriband (NTRB) United States $0.194B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.183B 0.00
Heat Biologics (HTBX) United States $0.182B 0.00
KemPharm (KMPH) United States $0.179B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.171B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.170B 0.00
Aziyo Biologics (AZYO) United States $0.163B 0.00
Genocea Biosciences (GNCA) United States $0.163B 0.00
Champions Oncology (CSBR) United States $0.156B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.150B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.143B 0.00
Otonomy (OTIC) United States $0.141B 0.00
MediWound (MDWD) Israel $0.139B 0.00
Lipocine (LPCN) United States $0.131B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.116B 0.00
ProPhase Labs (PRPH) United States $0.116B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.104B 0.00
Natural Alternatives (NAII) United States $0.100B 27.09
ElectroCore (ECOR) United States $0.099B 0.00
Assertio Holdings (ASRT) United States $0.097B 0.00
Baudax Bio (BXRX) United States $0.095B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.094B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.084B 0.00
Recro Pharma (REPH) United States $0.081B 0.00
PolarityTE (PTE) United States $0.078B 0.00
Biomerica (BMRA) United States $0.072B 0.00
Addex Therapeutics (ADXN) Switzerland $0.071B 0.00
CV Sciences (CVSI) United States $0.069B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.068B 0.00
Inhibikase Therapeutics (IKT) United States $0.067B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.065B 0.00
Brickell Biotech (BBI) United States $0.064B 0.00
Sigyn Therapeutics (SIGY) United States $0.062B 0.00
Plus Therapeutics (PSTV) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 26.15
Regulus Therapeutics (RGLS) United States $0.049B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.043B 0.00
Neos Therapeutics (NEOS) United States $0.042B 0.00
RXi Pharmaceuticals (PHIO) United States $0.040B 0.00
Mannatech (MTEX) United States $0.037B 5.47
China SXT Pharmaceuticals (SXTC) China $0.030B 0.00
Midatech Pharma (MTP) United Kingdom $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
Cyanotech (CYAN) United States $0.023B 19.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
JanOne (JAN) United States $0.020B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.015B 0.00
SHINECO INC (TYHT) China $0.013B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00